Samantha Du

Founder, Chairperson and CEO, Zai Lab

Shanghai, China

About

Samantha Du is the founder, Chairperson of the Board and Chief Executive Officer of Zai Lab, a commercial-stage biopharmaceutical company based in China and the United States. The company works in oncology, immunology, neuroscience and infectious disease, and its American depositary shares trade on Nasdaq under the symbol ZLAB, with ordinary shares listed in Hong Kong. Du has served on the board since 2014 and also sits on its Research and Development committee.

Du holds a Ph.D. in biochemistry from the University of Cincinnati and a B.S. in molecular biology from Jilin University in China. She began her research career at Pfizer in the United States, where she led its global metabolic licensing program from 1994 to 2001. She then co-founded Hutchison MediPharma, serving as its chief executive, and was a co-founder and chief scientific officer of Hutchison China MediTech until 2011. Later she worked at Sequoia Capital China, first as a healthcare partner and then as a venture partner. Other pharmaceutical leaders on Whoo include John Oyler of BeOne Medicines and Julie Kim of Takeda.

Whoo compiled this page from public sources: Zai Lab proxy statement (SEC, April 2026), Zai Lab leadership page, Zai Lab Form 8-K (SEC, November 2026). It is not affiliated with or endorsed by Samantha Du. Are you Samantha Du? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.

Want a page like this? Create yours from your résumé.

Experience

Founder, Chairperson and Chief Executive Officer — Zai Lab


Director since 2014 | Shanghai, China

  • Leads a biopharmaceutical company focused on oncology, immunology, neuroscience and infectious disease
  • Healthcare Partner and Venture Partner — Sequoia Capital China


    2012 – 2017

  • Healthcare Partner 2012 to 2014, Venture Partner 2014 to 2017
  • Co-founder and CEO — Hutchison MediPharma


    2001 – 2011

  • Also co-founder and Chief Scientific Officer of Hutchison China MediTech
  • Researcher — Pfizer


    1994 – 2001

  • Led the global metabolic licensing program

Education

Ph.D. in Biochemistry — University of Cincinnati

B.S. in Molecular Biology — Jilin University

Projects